Recent advances and novel treatment paradigms in acute lymphocytic leukemia

od Papadantonakis, Nikolaos, Advani, Anjali S.
izdano v Ther Adv Hematol (2016)

Management of older adults with acute lymphoblastic leukemia: challenges & current approaches

od Sawalha, Yazeed, Advani, Anjali S
izdano v Int J Hematol Oncol (2018)

Adult acute lymphocytic leukemia biology and treatment /

od Advani, Anjali S., Lazarus, Hillard M.
Izdano 2011

Navigating the nexus of MRD and novel agents in ALL

od Advani, Anjali S., Copelan, Edward A.
izdano v Hematology Am Soc Hematol Educ Program (2019)

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia

od Portell, Craig A, Wenzell, Candice M, Advani, Anjali S
Izdano 2013

Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukeaemia (OPAL): a randomized open-label phase 2 study

od Cortes, Jorge, Feldman, Eric, Yee, Karen, Rizzieri, David, Advani, Anjali S., Charman, Anthony, Spruyt, Richard, Toal, Martin, Kantarjian, Hagop
izdano v Lancet Oncol (2013)

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

od Sekeres, Mikkael A., Elson, Paul, Kalaycio, Matt E., Advani, Anjali S., Copelan, Edward A., Faderl, Stefan, Kantarjian, Hagop M., Estey, Elihu
Izdano 2009

SWOG0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Relapsed Acute Myeloid Leukaemia

od Advani, Anjali S., McDonough, Shannon, Copelan, Edward, Willman, Cheryl, Mulford, Deborah A., List, Alan F., Sekeres, Mikkael A., Othus, Megan, Appelbaum, Frederick R.
Izdano 2014

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

od Advani, Anjali S, Gibson, Sarah E, Douglas, Elizabeth, Jin, Tao, Zhao, Xiaoxian, Kalaycio, Matt, Copelan, Ed, Sobecks, Ronald, Sekeres, Mikkael, Sungren, Shawnda, Hsi, Eric D
Izdano 2010

SWOG S0910: A Phase 2 Trial of Clofarabine/Cytarabine/Epratuzumab for Relapsed/Refractory Acute Lymphocytic Leukaemia

od Advani, Anjali S., McDonough, Shannon, Coutre, Steven, Wood, Brent, Radich, Jerald, Mims, Martha, O’Donnell, Margaret, Elkins, Stephanie, Becker, Michael, Othus, Megan, Appelbaum, Frederick R.
Izdano 2014

A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605

od Sekeres, Mikkael A., Gundacker, Holly, Lancet, Jeffrey, Advani, Anjali, Petersdorf, Stephen, Liesveld, Jane, Mulford, Deborah, Norwood, Tom, Willman, Cheryl L., Appelbaum, Frederick R., List, Alan F.
Izdano 2011

Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

od Statler, Abby, Othus, Megan, Erba, Harry P., Chauncey, Thomas R., Radich, Jerald P., Coutre, Steven, Advani, Anjali, Nand, Sucha, Ravandi, Farhad, Mukherjee, Sudipto, Sekeres, Mikkael A.
izdano v Blood (2018)

Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline

od de Haas, Valérie, Ismaila, Nofisat, Advani, Anjali, Arber, Daniel A., Dabney, Raetasha S., Patel-Donnelly, Dipti, Kitlas, Elizabeth, Pieters, Rob, Pui, Ching-Hon, Sweet, Kendra, Zhang, Ling
izdano v J Clin Oncol (2019)

Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia (AML)

od Advani, Anjali S., Li, Hongli, Michaelis, Laura C., Medeiros, Bruno C., Liedtke, Michaela, List, Alan F., O’Dwyer, Kristen, Othus, Megan, Erba, Harry P., Appelbaum, Frederick R.
izdano v Leuk Res (2018)

P53-INDEPENDENT, NORMAL STEM CELL SPARING EPIGENETIC-DIFFERENTIATION THERAPY FOR MYELOID AND OTHER MALIGNANCIES

od Saunthararajah, Yogen, Triozzi, Pierre, Rini, Brian, Singh, Arun, Radivoyevitch, Tomas, Sekeres, Mikkael, Advani, Anjali, Tiu, Ramon, Reu, Frederic, Kalaycio, Matt, Copelan, Ed, Hsi, Eric, Lichtin, Alan, Bolwell, Brian
Izdano 2012

An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia

od Stock, Wendy, Diouf, Barthelemy, Crews, Kristine R., Pei, Deqing, Cheng, Cheng, Laumann, Kristina, Mandrekar, Sumithra J., Luger, Selina, Advani, Anjali, Stone, Richard M., Larson, Richard A., Evans, William E.
izdano v Clin Pharmacol Ther (2016)

Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms

od Visconte, Valeria, Przychodzen, Bartlomiej, Han, Yingchun, Nawrocki, Steffan T., Thota, Swapna, Kelly, Kevin R., Patel, Bhumika J., Hirsch, Cassandra, Advani, Anjali S., Carraway, Hetty E., Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Carew, Jennifer S.
izdano v Leukemia (2016)

A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia

od Kantarjian, Hagop M., Schuster, Michael W., Jain, Nitin, Advani, Anjali, Jabbour, Elias, Gamelin, Erick, Rasmussen, Erik, Juan, Gloria, Anderson, Abraham, Chow, Vincent F., Friberg, Gregory, Vogl, Florian D., Sekeres, Mikkael A.
izdano v Am J Hematol (2017)

The novel autophagy inhibitor ROC-325 augments the anti-leukemic activity of azacitidine

od Nawrocki, Steffan T., Han, Yingchun, Visconte, Valeria, Przychodzen, Bartlomiej, Espitia, Claudia M., Phillips, James, Anwer, Faiz, Advani, Anjali, Carraway, Hetty E., Kelly, Kevin R., Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Carew, Jennifer S.
izdano v Leukemia (2019)

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia

od Afable, Manuel G., Shaik, Mohammed, Sugimoto, Yuka, Elson, Paul, Clemente, Michael, Makishima, Hideki, Sekeres, Mikkael A., Lichtin, Alan, Advani, Anjali, Kalaycio, Matt, Tiu, Ramon V., O’Keefe, Christine L., Maciejewski, Jaroslaw P.
Izdano 2011